SKINVIVE™ by JUVÉDERM® Share Link click to copy Information Directions for Use Patient Labeling Consumer Website HCP Website JUVEDERM® and its design are trademarks of Allergan Holdings France SAS, an AbbVie company. SKYRIZI® risankizumab-rzaa Share Link click to copy Information...
This includes a total of six additional indications for RINVOQ and SKYRIZI, expanded indications for VENCLEXTA, and several other near-term product — new product approvals including atogepant, Navitoclax and ABBV-951. Clearly, this is a very exciting time for AbbVie, and I’m pleased with ...
AbbVie also achieved a number of regulatory milestones in markets worldwide for several key products, including regulatory approvals for Skyrizi for the treatment of active psoriatic arthritis (PsA), Qulipta for the preventive treatment of episodic migraine in adults, Vuity for the treatment of pr...